Breaking News Instant updates and real-time market news.

TGTX

TG Therapeutics

$7.11

-0.57 (-7.42%)

07:34
12/09/19
12/09
07:34
12/09/19
07:34

TG Therapeutics price target raised to $17 from $12 at B. Riley FBR

B. Riley FBR analyst Mayank Mamtani raised his price target for TG Therapeutics to $17 from $12 citing the company's "solid" Phase I/II triplet data. The data paint a "bright future," says the analyst, who reiterates a Buy rating on TG Therapeutics.

  • 09

    Dec

TGTX TG Therapeutics
$7.11

-0.57 (-7.42%)

03/29/19
CANT
03/29/19
INITIATION
Target $17
CANT
Overweight
TG Therapeutics initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young initiated TG Therapeutics with an Overweight and $17 price target.
03/29/19
CANT
03/29/19
INITIATION
Target $17
CANT
Overweight
Cantor starts TG Therapeutics with Overweight rating, $17 price target
Cantor Fitzgerald analyst Alethia Young initiated coverage of TG Therapeutics with an Overweight rating and $17 price target. The analyst believes umbralisib and ublituximab have attractive profiles in oncology and autoimmune B-cell diseases. Investors are cautious on the PI3K commercial potential and give no credit to multiple sclerosis due to the competitive yet price sensitive landscape, but both lead assets as clinically de-risked with proven targets, Young tells investors in a research note. She thinks the risk/reward on TG shares is positive.
04/12/19
HCWC
04/12/19
NO CHANGE
Target $20
HCWC
Buy
TG granted orphan status for three lymphoma indications, says H.C. Wainwright
The FDA granted TG Therapeutics' umbralisib orphan drug status for three lymphoma indications, H.C. Wainwright analyst Edward White tells investors in a research note. The analyst continues to believe umbralisib will be launched in 2021, generating sales of $10.6M, growing to $141.5M in 2027. He keeps a Buy rating on TG Therapeutics with a $20 price target.
11/27/19
RILY
11/27/19
INITIATION
Target $12
RILY
Buy
TG Therapeutics resumed with a Buy at B. Riley FBR
B. Riley FBR resumed coverage of TG Therapeutics with a Buy rating and $12 price target.

TODAY'S FREE FLY STORIES

CDE

Coeur Mining

$5.86

-1.17 (-16.64%)

05:41
01/21/20
01/21
05:41
01/21/20
05:41
Downgrade
Coeur Mining rating change  »

Coeur Mining downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

LGF.B

Lionsgate

$10.32

-0.305 (-2.87%)

05:39
01/21/20
01/21
05:39
01/21/20
05:39
Downgrade
Lionsgate rating change  »

Lionsgate downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

USB

U.S. Bancorp

$55.33

0.14 (0.25%)

05:36
01/21/20
01/21
05:36
01/21/20
05:36
Downgrade
U.S. Bancorp rating change  »

U.S. Bancorp downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 15

    Apr

CHGG

Chegg

$43.36

0.64 (1.50%)

05:34
01/21/20
01/21
05:34
01/21/20
05:34
Recommendations
Chegg analyst commentary  »

Chegg price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

  • 19

    Feb

ROKU

Roku

$130.35

-0.76 (-0.58%)

05:33
01/21/20
01/21
05:33
01/21/20
05:33
Hot Stocks
Roku announces arrival in Brazil through partnership with AOC »

Roku announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

RNR

RenaissanceRe

$193.19

0.235 (0.12%)

05:32
01/21/20
01/21
05:32
01/21/20
05:32
Initiation
RenaissanceRe initiated  »

RenaissanceRe initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 26

    Feb

RE

Everest Re

$279.96

2.455 (0.88%)

05:31
01/21/20
01/21
05:31
01/21/20
05:31
Initiation
Everest Re initiated  »

Everest Re initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

COST

Costco

$304.68

1.83 (0.60%)

05:31
01/21/20
01/21
05:31
01/21/20
05:31
Upgrade
Costco rating change  »

Costco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Mar

HIG

Hartford Financial

$61.20

0.925 (1.53%)

05:30
01/21/20
01/21
05:30
01/21/20
05:30
Initiation
Hartford Financial initiated  »

Hartford Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

UBS

UBS

$13.13

-0.06 (-0.45%)

05:29
01/21/20
01/21
05:29
01/21/20
05:29
Hot Stocks
UBS agrees to sell majority stake in UBS Fondcenter to Clearstream »

UBS Group AG and UBS AG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

AIG

AIG

$52.88

0.52 (0.99%)

05:29
01/21/20
01/21
05:29
01/21/20
05:29
Initiation
AIG initiated  »

AIG initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRV

Travelers

$140.72

1.85 (1.33%)

05:28
01/21/20
01/21
05:28
01/21/20
05:28
Initiation
Travelers initiated  »

Travelers initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CB

Chubb

$153.67

1 (0.66%)

05:28
01/21/20
01/21
05:28
01/21/20
05:28
Initiation
Chubb initiated  »

Chubb initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

PGR

Progressive

$76.29

0.85 (1.13%)

05:27
01/21/20
01/21
05:27
01/21/20
05:27
Initiation
Progressive initiated  »

Progressive initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALL

Allstate

$117.54

1.39 (1.20%)

05:26
01/21/20
01/21
05:26
01/21/20
05:26
Initiation
Allstate initiated  »

Allstate initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 26

    Feb

  • 13

    Mar

UBS

UBS

$13.13

-0.06 (-0.45%)

05:26
01/21/20
01/21
05:26
01/21/20
05:26
Hot Stocks
UBS targeting RoCET1 of 12%-15% om 2020-2022 »

UBS provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

WLTW

Willis Towers Watson

$204.95

0.76 (0.37%)

05:25
01/21/20
01/21
05:25
01/21/20
05:25
Initiation
Willis Towers Watson initiated  »

Willis Towers Watson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 28

    Jan

  • 06

    Feb

  • 10

    Feb

  • 11

    Feb

  • 11

    Feb

MMC

Marsh & McLennan

$114.11

1.32 (1.17%)

05:24
01/21/20
01/21
05:24
01/21/20
05:24
Initiation
Marsh & McLennan initiated  »

Marsh & McLennan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

AON

Aon plc

$211.77

1.66 (0.79%)

05:24
01/21/20
01/21
05:24
01/21/20
05:24
Initiation
Aon plc initiated  »

Aon plc initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 31

    Jan

  • 26

    Feb

UBS

UBS

$13.13

-0.06 (-0.45%)

05:24
01/21/20
01/21
05:24
01/21/20
05:24
Earnings
UBS reports Q4 EPS 19c, one estimate 18c »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

PING

Ping Identity

$25.68

-0.34 (-1.31%)

05:19
01/21/20
01/21
05:19
01/21/20
05:19
Downgrade
Ping Identity rating change  »

Ping Identity downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNG

RingCentral

$192.99

2.36 (1.24%)

, AVYA

Avaya

$12.97

(0.00%)

05:17
01/21/20
01/21
05:17
01/21/20
05:17
Upgrade
RingCentral, Avaya rating change  »

RingCentral upgraded to…

RNG

RingCentral

$192.99

2.36 (1.24%)

AVYA

Avaya

$12.97

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$46.57

-0.37 (-0.79%)

05:15
01/21/20
01/21
05:15
01/21/20
05:15
Earnings
Logitech backs FY20 revenue guidance of mid to high single-digit growth »

Backs FY20 non-GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

GLNCY

Glencore

$0.00

(0.00%)

05:14
01/21/20
01/21
05:14
01/21/20
05:14
Upgrade
Glencore rating change  »

Glencore upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$46.57

-0.37 (-0.79%)

05:14
01/21/20
01/21
05:14
01/21/20
05:14
Earnings
Logitech reports Q3 EPS 84c, consensus 79c »

Reports Q3 revenue $903M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.